Cancer is one of the biggest health challenges facing humanity and the scientific community has attempted different approaches to overcome the limitations of the current therapies. Over the past two decades, the world witnessed a steady growth in the development of many applications that utilize nanomaterials to enhance the potential of cancer therapeutics. Nanotechnology provides a wide range of efficient drug delivery systems that show great promise by increasing tumor selectivity and decreasing side effects towards fully eradicating tumor cells, as well as the successes achieved with immunotherapy in the treatment of multiple cancers.
While the future of cancer nanotherapeutics looks very promising, there are still limitations and challenges that restrict their clinical potential. Although some nanomaterials have been approved for clinical applications in cancer therapy, the available evidence on their effects on survival has been modest. However, the successes achieved with multifunctional nanotherapeutics have revolutionized the field of cancer nanotherapy.
Multifunctional nanotherapeutics have been fabricated to overcome the limitations and challenges of conventional nanotherapeutics. Compared to conventional nanotherapeutics, these nanotherapeutics have enhanced efficacy to perform multiple goals synergistically, such as the co-delivery of multiple bioactive molecules that target different cellular and microenvironment mechanisms in cancer.
The aim of this research topic is to highlight state-of-the-art nanotechnology research on cancer therapy. High priority will be given to research on the anticancer potentials of nanotherapeutics with multi-functionalities. This research topic will address the recent advances and the future directions of research on multifunctional cancer nanotherapeutics so that readers can have a broad overview of this interesting research area spanning from the fundamentals to the potentials and advantages of these nanotherapeutics. Works published in this collection should be of particular interest to researchers who are investigating the anticancer potentials of multifunctional nanotherapeutics and those who plan to overcome the hinders of conventional nanotherapeutics.
The topic will accept a wide range of manuscripts under (but not limited to) the following themes:
• Synthesis and characterization of nanocarriers with potential multi-functionalities for cancer therapy
• Cytotoxicity and biocompatibility assessment of multifunctional nanotherapeutics
• Kinetic and mechanistic evaluation of multifunctional anticancer nanotherapeutics
• Potentiation of in-vivo anticancer efficacy of therapeutic molecules by multifunctional nanocarriers
• Promising nano-delivery systems for cancer immunotherapy
We encourage the submission of original research and review articles, but the topic may also include perspectives, clinical trials, case reports, and opinions.
Cancer is one of the biggest health challenges facing humanity and the scientific community has attempted different approaches to overcome the limitations of the current therapies. Over the past two decades, the world witnessed a steady growth in the development of many applications that utilize nanomaterials to enhance the potential of cancer therapeutics. Nanotechnology provides a wide range of efficient drug delivery systems that show great promise by increasing tumor selectivity and decreasing side effects towards fully eradicating tumor cells, as well as the successes achieved with immunotherapy in the treatment of multiple cancers.
While the future of cancer nanotherapeutics looks very promising, there are still limitations and challenges that restrict their clinical potential. Although some nanomaterials have been approved for clinical applications in cancer therapy, the available evidence on their effects on survival has been modest. However, the successes achieved with multifunctional nanotherapeutics have revolutionized the field of cancer nanotherapy.
Multifunctional nanotherapeutics have been fabricated to overcome the limitations and challenges of conventional nanotherapeutics. Compared to conventional nanotherapeutics, these nanotherapeutics have enhanced efficacy to perform multiple goals synergistically, such as the co-delivery of multiple bioactive molecules that target different cellular and microenvironment mechanisms in cancer.
The aim of this research topic is to highlight state-of-the-art nanotechnology research on cancer therapy. High priority will be given to research on the anticancer potentials of nanotherapeutics with multi-functionalities. This research topic will address the recent advances and the future directions of research on multifunctional cancer nanotherapeutics so that readers can have a broad overview of this interesting research area spanning from the fundamentals to the potentials and advantages of these nanotherapeutics. Works published in this collection should be of particular interest to researchers who are investigating the anticancer potentials of multifunctional nanotherapeutics and those who plan to overcome the hinders of conventional nanotherapeutics.
The topic will accept a wide range of manuscripts under (but not limited to) the following themes:
• Synthesis and characterization of nanocarriers with potential multi-functionalities for cancer therapy
• Cytotoxicity and biocompatibility assessment of multifunctional nanotherapeutics
• Kinetic and mechanistic evaluation of multifunctional anticancer nanotherapeutics
• Potentiation of in-vivo anticancer efficacy of therapeutic molecules by multifunctional nanocarriers
• Promising nano-delivery systems for cancer immunotherapy
We encourage the submission of original research and review articles, but the topic may also include perspectives, clinical trials, case reports, and opinions.
